Sort
51,593 grants matching “hepatitis”
Endothelial Barrier Function Regulation by VEGF
$385,000University Of California San Diego · R01 · FY2005 · HL
The role of PON2 and PON3 proteins in atherosclerosis
$385,000Srinivasa Reddy · University Of California Los Angeles · R01 · FY2016 · HL
Advancing a novel therapy for preeclampsia
$385,000Bo Yu · Larix Bioscience, Llc · R43 · FY2022 · HD
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation
$385,000Peter J Tontonoz · University Of California Los Angeles · P01 · FY2015 · HL
Subtype Specific LXR Activity Limits Atherosclerosis
$385,000Ira G Schulman · University Of Virginia · R01 · FY2010 · HL
Alterations of aryl hydrocarbon receptor signaling in autoimmune hepatitis
$385,000Maria Serena Longhi · Beth Israel Deaconess Medical Center · R01 · FY2022 · DK
Post-Translational Regulation of Lipid Metabolism
$385,000Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2018 · HL
Cell-specific and multifunctional drug formulations for in vivo delivery
$385,000Yizhou Dong · Ohio State University · R35 · FY2019 · GM
Exploring the pathophysiology and treatment of LCHADD retinopathy
$385,000Melanie B Gillingham · Oregon Health & Science University · R01 · FY2021 · EY
TLR-4 IN LIVER IMMUNOREGULATION
$385,000Ian Nicholas Crispe · University Of Rochester · R56 · FY2007 · AI
Adiponectin Actions on the Monocyte to Reduce Atherosclerosis
$385,000Rajendra K Tangirala · University Of California Los Angeles · R01 · FY2010 · HL
Killing Multi-Drug Resistant Pseudomonas aeruginosa
$385,000Linda D Hazlett · Wayne State University · R01 · FY2019 · EY
Novel role of endoplasmic reticulum-associated degradation in iron metabolism
$385,000Shengyi Sun · Wayne State University · R01 · FY2022 · DK
Adiponectin Actions on the Monocyte to Reduce Atherosclerosis
$385,000Rajendra K Tangirala · University Of California Los Angeles · R01 · FY2009 · HL
Alterations of aryl hydrocarbon receptor signaling in autoimmune hepatitis
$385,000Maria Serena Longhi · Beth Israel Deaconess Medical Center · R01 · FY2021 · DK
Linked: HIV-Associated Malignancies in Malawi
$385,000Johnstone Jonny Kumwenda · University Of Malawi · R24 · FY2011 · TW
Symptom burden in End-Stage Liver Disease patient-caregiver dyads
$385,000Lissi Hansen · Oregon Health & Science University · R01 · FY2016 · NR
Symptom burden in End-Stage Liver Disease patient-caregiver dyads
$385,000Lissi Hansen · Oregon Health & Science University · R01 · FY2018 · NR
Regulation of ApoB Lipoprotein Expansion and Hepatic Lipid Efflux by ApoA-IV
$385,000John S Parks · Wake Forest University Health Sciences · R01 · FY2014 · HL
Exploring the pathophysiology and treatment of LCHADD retinopathy
$385,000Melanie B Gillingham · Oregon Health & Science University · R01 · FY2023 · EY
Cell-specific and multifunctional drug formulations for in vivo delivery
$385,000Yizhou Dong · Ohio State University · R35 · FY2020 · GM
Post-Translational Regulation of Lipid Metabolism
$385,000Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2021 · HL
Linked: HIV-Associated Malignancies in Malawi
$385,000Steve Kamiza · University Of Malawi · R24 · FY2014 · TW
Post-Translational Regulation of Lipid Metabolism
$385,000Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2017 · HL
Transcriptional control of microRNAs in lipid metabolism and atherosclerosis
$385,000Thomas A Vallim · University Of California Los Angeles · R01 · FY2016 · HL